Full Text View
Tabular View
No Study Results Posted
Related Studies
Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation (AFSP)
This study is currently recruiting participants.
Verified March 2012 by University of Alabama at Birmingham
Study NCT01134731   Information provided by University of Alabama at Birmingham

First Received on May 20, 2010.   Last Updated on March 15, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Major Depressive Disorder
Suicidality
Additional conditions recognized in this trial
Depression
Depressive Disorder
Depressive Disorder, Major
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
paliperidone
placebo
lithium
Additional drug interventions recognized in this trial
9-hydroxy-risperidone
Lithium Carbonate
More general drug interventions related to this trial
Antidepressive Agents
Antimanic Agents
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
University of Alabama at Birmingham
American Foundation for Suicide Prevention
Ortho-McNeil Janssen Scientific Affairs, LLC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services